Clinical Trial Update: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing rapamycine to placebo for inclusion body myositis has completed (Phase 2/Phase 3); no efficacy results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inclusion Body Myositis

Drugs mentioned

• Rapamycine (sirolimus)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Inclusion Body Myositis (IBM) | Phase 2, Phase 3 | Status: COMPLETED